Literature DB >> 9368049

A single chain Fv fragment of P-glycoprotein-specific monoclonal antibody C219. Design, expression, and crystal structure at 2.4 A resolution.

F J Hoedemaeker1, T Signorelli, K Johns, D A Kuntz, D R Rose.   

Abstract

A construct encoding a single chain variable fragment of the anti-P-glycoprotein monoclonal antibody C219 was made by combining the coding sequences for the heavy and light chain variable domains with a sequence encoding the flexible linker (GGGGS)3, an OmpA signal sequence, a c-myc identification tag, and a five-histidine purification tag. The construct was expressed in Escherichia coli and purified from the periplasmic fraction using a nickel chelate column and ion exchange chromatography. Three-step Western blot analysis showed that the construct retains binding affinity for P-glycoprotein. Crystals of 1.0 x 0.2 x 0.2 mm were grown in 100 mM citrate, pH 4.5, 21% polyethylene glycol 6000 in the presence of low concentrations of subtilisin, resulting in proteolytic removal of the linker and purification tags. The structure was solved to a resolution of 2.4 A with an R factor of 20.6, an Rfree of 28.5, and good stereochemistry. This result could lead to a clinically useful product based on antibody C219 for the diagnosis of P-glycoprotein-mediated multidrug resistance. The molecule will also be useful in biophysical studies of functional domains of P-glycoprotein, as well as studies of the intact molecule.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9368049     DOI: 10.1074/jbc.272.47.29784

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  6 in total

1.  Antibody C219 recognizes an alpha-helical epitope on P-glycoprotein.

Authors:  J M van Den Elsen; D A Kuntz; F J Hoedemaeker; D R Rose
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-23       Impact factor: 11.205

2.  Method for targeting protein destruction by using a ubiquitin-independent, proteasome-mediated degradation pathway.

Authors:  Shu-ichi Matsuzawa; Michael Cuddy; Toru Fukushima; John C Reed
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-11       Impact factor: 11.205

Review 3.  Expression and secretion of proteins in E. coli.

Authors:  O Pines; M Inouye
Journal:  Mol Biotechnol       Date:  1999-08       Impact factor: 2.695

4.  Crystal structure of the anti-(carcinoembryonic antigen) single-chain Fv antibody MFE-23 and a model for antigen binding based on intermolecular contacts.

Authors:  M K Boehm; A L Corper; T Wan; M K Sohi; B J Sutton; J D Thornton; P A Keep; K A Chester; R H Begent; S J Perkins
Journal:  Biochem J       Date:  2000-03-01       Impact factor: 3.857

5.  Transmembrane helix 12 modulates progression of the ATP catalytic cycle in ABCB1.

Authors:  Emily Crowley; Megan L O'Mara; Catherine Reynolds; D Peter Tieleman; Janet Storm; Ian D Kerr; Richard Callaghan
Journal:  Biochemistry       Date:  2009-07-07       Impact factor: 3.162

6.  Improved scFv Anti-LOX-1 Binding Activity by Fusion with LOX-1-Binding Peptides.

Authors:  Wei Hu; Qiuhong Xie; Hongyu Xiang
Journal:  Biomed Res Int       Date:  2017-09-28       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.